Published in BMJ on December 01, 2010
Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99
HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23
High risk of HIV in non-brothel based female sex workers in India. BMC Public Health (2005) 3.58
Sex behaviour of men who have sex with men and risk of HIV in Andhra Pradesh, India. AIDS (2005) 3.35
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet (2004) 3.14
Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J Urban Health (2006) 3.04
Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico. AIDS (2006) 2.87
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55
Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health (2006) 2.44
Making HIV prevention programmes work. Lancet (2008) 2.22
Combination HIV prevention. Lancet (2008) 2.10
Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics (2011) 1.89
Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework. AIDS (2008) 1.87
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet (2013) 1.85
Demography and sex work characteristics of female sex workers in India. BMC Int Health Hum Rights (2006) 1.76
HIV prevention cost-effectiveness: a systematic review. BMC Public Health (2009) 1.58
How the Avahan HIV prevention program transitioned from the Gates Foundation to the government of India. Health Aff (Millwood) (2013) 1.50
Emergency contraception use is correlated with increased condom use among adolescents: results from Mexico. J Adolesc Health (2004) 1.33
Evaluation of large-scale combination HIV prevention programs: essential issues. J Acquir Immune Defic Syndr (2011) 1.32
Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010. Health Policy (2012) 1.31
Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS One (2009) 1.24
The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico. PLoS One (2007) 1.18
Variations in prenatal care quality for the rural poor in Mexico. Health Aff (Millwood) (2007) 1.17
Factors influencing global antiretroviral procurement prices. BMC Public Health (2009) 1.16
Community-based prevention leads to an increase in condom use and a reduction in sexually transmitted infections (STIs) among men who have sex with men (MSM) and female sex workers (FSW): the Frontiers Prevention Project (FPP) evaluation results. BMC Public Health (2010) 1.15
Risk behaviors of 15-21 year olds in Mexico lead to a high prevalence of sexually transmitted infections: results of a survey in disadvantaged urban areas. BMC Public Health (2006) 1.13
Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One (2013) 1.11
HIV prevention in Mexican schools: prospective randomised evaluation of intervention. BMJ (2006) 1.09
Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. AIDS (2007) 1.09
Learning effect of a conditional cash transfer programme on poor rural women's selection of delivery care in Mexico. Health Policy Plan (2011) 1.04
The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis. PLoS One (2013) 1.04
Costing of scaling up HIV/AIDS treatment in Mexico. Salud Publica Mex (2008) 1.02
How much attention is needed towards men who sell sex to men for HIV prevention in India? BMC Public Health (2006) 1.02
HIV testing among female sex workers in Andhra Pradesh, India. AIDS (2005) 1.01
Correlates of condom use in a sample of MSM in Ecuador. BMC Public Health (2006) 0.99
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis (2008) 0.96
High prevalence of obesity among the poor in Mexico. JAMA (2004) 0.95
Willingness-to-accept reductions in HIV risks: conditional economic incentives in Mexico. Eur J Health Econ (2013) 0.95
Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health (2012) 0.95
[Antibiotic use in Mexico: review of problems and policies]. Salud Publica Mex (2008) 0.93
Financing HIV programming: how much should low- and middle-income countries and their donors pay? PLoS One (2013) 0.92
Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg (2008) 0.91
Evaluation of HIV prevention programmes: the case of Avahan. Sex Transm Infect (2010) 0.89
Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting. Health Policy Plan (2003) 0.88
Optimizing HIV treatment programs. Curr Opin HIV AIDS (2010) 0.87
Access to condoms for female sex workers in Andhra Pradesh. Natl Med J India (2007) 0.86
Organizational elements of health service related to a reduction in maternal mortality: the cases of Chile and Colombia. Health Policy (2008) 0.86
Cost of AIDS care in Mexico: what are its main individual predictors? Arch Med Res (2005) 0.84
Strategies and ethical considerations for the recruitment of young men who have sex with men: challenges of a vaccination trial in Mexico. Clin Trials (2009) 0.84
Can cost studies improve the performance of donor-financed HIV treatment? AIDS (2011) 0.81
Herpes simplex virus type 2 among Mexican high school adolescents: prevalence and association with community characteristics. Arch Med Res (2007) 0.80
[A novel school-based strategy for the prevention of HIV/AIDS, sexually transmitted disease (STDs), and teen pregnancies]. Salud Publica Mex (2006) 0.80
A new entity for the negotiation of public procurement prices for patented medicines in Mexico. Bull World Health Organ (2012) 0.80
[The debate on self medication]. Salud Publica Mex (2009) 0.79
[Facing the HIV/AIDS epidemic in Mexico: the response of the health sector]. Rev Invest Clin (2004) 0.79
The economic impacts of HIV/AIDS on households and economies. AIDS (2008) 0.79
Improving enrollment and utilization of the Oportunidades program in Mexico could increase its effectiveness. J Nutr (2008) 0.79
Reforming antiretroviral price negotiations and public procurement: the Mexican experience. Health Policy Plan (2012) 0.79
Stakeholders' opinions and expectations of the Global Fund and their potential economic implications. AIDS (2008) 0.78
A predictive model for the utilization of curative ambulatory health services in Mexico. Salud Publica Mex (2008) 0.78
Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico. BMC Health Serv Res (2010) 0.78
Operational rules for the implementation of INN prescribing. Int J Med Inform (2013) 0.78
Social network recruitment for Yo Puedo: an innovative sexual health intervention in an underserved urban neighborhood—sample and design implications. J Prim Prev (2015) 0.78
Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico. Bull World Health Organ (2012) 0.77
[Supply prescription filling and out-of-pocket expenditures on medicines in public hospitals in Mexico in 2009]. Salud Publica Mex (2011) 0.76
Impact and economic evaluations of a combination prevention programme for men who have sex with men in Mexico. AIDS (2016) 0.76
[Active tuberculosis in a cohort of HIV-infected inmates in a prison in Mexico City: clinical and epidemiological characteristics]. Salud Publica Mex (2013) 0.76
Implementation and Operational Research: Effect of Universal Access to Antiretroviral Therapy on HIV/AIDS Mortality in Mexico 1990-2011. J Acquir Immune Defic Syndr (2015) 0.76
[Influenza vaccination in the elderly population in Mexico: economic considerations]. Salud Publica Mex (2005) 0.76
Modeling the impact of antiretroviral use in developing countries. PLoS Med (2006) 0.75
Scaling up HAART in Mexico. Response to Volkow et al. AIDS (2007) 0.75
Measuring universities' commitments to global health. Lancet (2013) 0.75
[Smoking cessation interventions in Mexico: analysis of the willingness to pay for an effective method to quit]. Salud Publica Mex (2012) 0.75
A literature review of reporting standards of HIV progression models. AIDS (2012) 0.75
[The health gap in Mexico, measured through child mortality]. Salud Publica Mex (2003) 0.75
[Research to support pharmaceutical policies]. Salud Publica Mex (2008) 0.75
Combining evidence for access to and benefits from antiretroviral treatment to inform planning. AIDS (2008) 0.75
Informing scale-up and resource allocation: the use of economic analysis. AIDS (2008) 0.75
Post-emergency: providing effective, sustainable, life-long care to everyone with AIDS. Indian J Med Res (2006) 0.75
The maximum willingness to pay for smoking cessation method among adult smokers in Mexico. Value Health (2012) 0.75
[Mixed design for the evaluation of the Mesoamerica Health 2015 initiative]. Salud Publica Mex (2011) 0.75
Access to medicines among internally displaced and non-displaced people in urban areas in Colombia. Cad Saude Publica (2012) 0.75
[Cost-effectiveness of breast cancer screening policies in Mexico]. Salud Publica Mex (2009) 0.75